European Society for Paediatric Infectious Diseases (ESPID)
1-3 Rue Chantepoulet
The European Society for Paediatric Infectious Diseases (ESPID) exists to promote the exchange of information among people who have special experience in the field of paediatric infectious diseases. The society promotes research and training in PID. ESPID holds its annual meetings in different European locations chosen in a bid process. Membership is granted to individuals supported by at least one existing member at the discretion of the Board. ESPID members receive on a monthly basis The Pediatric Infectious Disease Journal and can benefit from a number of award schemes.
15 Stanhope Gate
LONDON, W15 1LN
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of US $32.8 billion in 2009. For more information please visit: www.astrazeneca.com
PO Box 51
ArcDia Group is a company for development and marketing of innovative immunoassay products. ArcDia is focused on point-of-care and near-patient testing of infectious diseases with special emphasis on respiratory tract infections.
ArcDia offers automated random-access immunoanalysers, which are designed for multianalyte POC and near-patient testing. The analysers are bench-top in size, highly sensitive and easy-to-use.
ArcDia's product portfolio includes multianalyte tests for the upper respiratory infection (URI) and lower respiratory infection (LRI) and pharyngitis. A new multianalyte respiratory infection test system available now for also distribution and in-licensing.
Industriestrasse 67, A-1221
Baxter is dedicated to improving public health worldwide. Baxter technologies have the potential to open the door to a new generation of vaccines, to protect against both bacteria and viruses.
Baxter currently has three licensed vaccines:
- FSME-IMMUN, against tick-borne encephalitis (TBE)
- NeisVac-C, a group C meningococcal conjugate vaccine
- CELVAPAN, the first licensed cell-culture based pandemic influenza vaccine
- and is developing innovative vaccines: a cell-culture based seasonal influenza vaccine
- a Ross River vaccine
- a vaccine against Chikungunya
Baxter’s mission is the prevention of a broad spectrum of infectious diseases in infants, children and adults.
PO Box 11712
Binding Site, a specialist protein company, is committed to improving patient care through the development of assays for the diagnosis of immunological disorders. For many years Binding Site has been producing high quality products for the investigation of Primary Immunodeficiency and the measurement of the specific antibody response to vaccination.
Immunoglobulin and subclass assays are now available on our new benchtop turbidimetric analyser, SPAPLUS. The VaccZyme™ product range offers ELISA kits with a high level of precision and reliability with kits for the measurement of specific IgG against Tetanus, Diphtheria, Haemophilus influenza type b, Streptococcus pneumoniae (Pneumovax™), Salmonella typhi vi and VZV.
Chemin de l’Orme
69280 Marcy l’Etoile
bioMérieux, a world leader in the field of in vitro diagnostics, offers an extensive range of high-medical value solutions for infectious diseases.
Key pediatric applications include:
- VIDAS® B.R.A.H.M.S PCT: improves accuracy of sepsis diagnosis and guides antibiotic prescription.
- A Viral Respiratory Disease offer, comprising QuickVUE™ rapid tests(<
10-15 minutes) for RSV, Influenza A+B, Strepto A, and NucliSENS EasyQ® molecular tests (<2-3 hours) for RSV, Influenza and hMPV.
- The NucliSENS EasyQ Central Nervous System (CNS) Panel for detection of Enterovirus and Herpes Simplex Virus 1/2.
Visit us on Booth 5 and discover our full range of applications
Cepheid is delivering a better way to realize the benefits of molecular diagnostics. Every day, we are transforming healthcare with our revolutionary approach to molecular testing. Our unique combination of accuracy, speed, and ease-of- use puts us generations beyond other molecular solutions.
The GeneXpert System is the first platform to fully automate and integrate all the steps required for PCR-based DNA testing: sample preparation, amplification and detection.
The Xpert® tests menu includes: Enteroviral Meningitis, Group B strep for intrapartum testing, Flu, Tuberculosis complex and RIF resistance, MRSA Surveillance, MRSA/SA SSTI, MRSA/SA Blood Culture, MRSA/SA presurgical, Clostridium difficile, vanA/vanB, BCR-ABL and HemosIL® FII&V.
2333 CN Leiden
Crucell is dedicated to bringing innovation to global health by developing & marketing products that combat infectious diseases. Crucell candidates include flu-mAb, an antibody effective against a broad range of influenza virus strains, tuberculosis and malaria vaccines, and a rabies monoclonal antibody combination – all produced on our unique PER.C6® cell-based technology. We focus on the paediatric, travel & endemic and respiratory markets. Our core portfolio includes Quinvaxem®, a liquid pentavalent vaccine against five important childhood diseases; Epaxal®, the only aluminum-free hepatitis A vaccine on the market;Vivotif® and Dukoral®, oral vaccines against typhoid & cholera, and Inflexal® V, a virosomal adjuvanted vaccine against influenza.
rue Ettore Bugatti BP48053
67038 Strasbourg Cedex 2
DectraPharm company is member of Prodiag group dedicated to diagnostic.
DectraPharm has obtained for the second time the European tender organized by French social security CNAMTS in order to provide all French doctors and hospitals with angina test EXACTO STREPTATEST® as part of operation “Les Antibiotiques c’est pas automatique”.
DectraPharm also provides pharmacists, doctors and institutions with pregnancy, fertility, infection tests and URITOP® urine strips under the brand name EXACTO®
DectraPharm’s sister company ALLDIAG is dedicated to provide rapid tests under EXACTO® brand name to public and private laboratories, hospitals and Clinics.
SBH, an other DectraPharm’s sister company is dedicated to manufacture OEM diagnostic products for many European pharmaceutical laboratories and distributors.
Biosynex, partner company of Prodiag group, is in charge of research development and production of rapid tests mainly for the count of ALLDIAG.
89, rue de l’Institut
GlaxoSmithKline Biologicals (GSK Biologicals), GlaxoSmithKline’s vaccines business, is one of the world’s leading vaccine companies and a leader in innovation. The company is active in vaccine research, development and production with over 30 vaccines approved for marketing and 20 more in development - both in the prophylactic and therapeutic fields. Headquartered in Belgium, GSK Biologicals has 15 manufacturing sites strategically positioned around the globe. In 2009, GSK Biologicals distributed 1.4 billion doses of vaccines – of which 130 million H1N1 vaccine doses - to 182 countries in both the developed and the developing world.
Through its accomplished and dedicated workforce, GSK Biologicals applies its expertise to the discovery of innovative vaccines that contribute to the health and well-being of people of all generations around the world.
GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information, please visit www.gsk.com
The Hague Convention & Visitors Bureau
P.O. Box 85456
The Hague, 2508 CD
Convention Bureau The Hague promotes the city as a destination for congresses, symposiums, company events, incentives and other business meetings. The City of The Hague is our main partner. This enables us to maintain complete independence in our advisory services.
We offer the following (mostly free) services to potential organisers:
- Independent, tailor-made advice on accommodation and other relevant services.
- Co-ordination and organisation of site inspections for potential organisers, enabling them to make the most informed choice.
- Lending assistance for large scale projects during the co-ordination of availability of locations, hotel accommodation and other services.
- Advice on social and partner programmes.
- Setting up communications between organisers and selected businesses and organisations when desired.
4906 CR OOSTERHOUT
Luminex Corporation develops manufactures and markets proprietary biological testing technologies with applications throughout the diagnostics and life sciences industries. The Company’s xMAP® multiplex solutions include an open architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics markets. The Company’s xMAP technology is sold worldwide and is already is use in leading clinical laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Further information on Luminex Corporations or xMAP can be obtained at www.luminexcorp.com
One MedImmune Way
Gaithersburg, MD 20878
MedImmune, the worldwide biologics business for AstraZeneca PLC (LSE: AZN.L, NYSE: AZN), has approximately 3,300 employees worldwide and is headquartered in Gaithersburg, Maryland. For more information, visit MedImmune’s website at www.medimmune.com
4088 Commercial Avenue
Northbrook, IL, 60062
Nanosphere, Inc. (Northbrook, IL, USA) has developed the Verigene® System, which is comprised of instrumentation and single use Verigene® Test Cartridges based on proprietary, gold nanoparticle probe technology. With the Verigene System, users can accomplish sample-to-result test processing for multiplex targets that is sensitive, accurate, and rapid. CE-IVD assays will be available soon for use on the Verigene System, including Respiratory Virus Panels (Panel I: Influenza A incl. subtyping and oseltamivir resistance, Influenza B, and RSV; Panel II: human Metapneumovirus, Parainfluenza 1-3, and Adenovirus), and Pharmacogenomic Panels (CYP2C19 polymorphism panel; Warfarin Metabolism panel). Additional tests will be available in 2010/11.
Novartis Vaccines & Diagnostics, Inc.
350 Massachusetts Avenue, Cambridge
“Caring Begins with Prevention”
At Novartis Vaccines and Diagnostics, we believe that caring for patients begins with protecting individuals and societies from infection in the first place.
The division has two businesses: Novartis Vaccines and Novartis Diagnostics.
Novartis Vaccines is the world’s fifth-largest vaccines manufacturer and the second-largest supplier of influenza vaccines in the US. The division's products also include meningococcal, pediatric and travel vaccines.
Novartis Diagnostics is dedicated to providing innovative testing solutions to protect the world’s blood supply from transfusion-transmitted diseases. We are the world leader in nucleic acid testing for blood screening.
1/B Saguna, 271/B St. Francis Road,
Vile Parle (W)
PEDIATRIC ONCALL is a premier pediatric e-journal offering latest medical updates, peer reviewed scientific articles, case reports. grand rounds, spot diagnosis, pediatric calculators, patient management tools, podcasts, vaccine tools, drug directory and much more. Established in November 2000, it has an excellent track record of regular updates and is extremely popular amongst its viewers. A current hit rate of 1,50,000hits/day is no mean achievement and over 60,000 doctors as its members, it serves as an important source of updating themselves.
It’s a free medical service to doctors and parents. All you need to do is register for free to access the e-journal on www.pediatriconcall.com
P.le Cocchi, 12
21040 Vedano Olona (VA) - ITALY
Tecnimed is the manufacturer of Thermofocus®, the first and unique non-contact clinical thermometer in the world with an exclusive aiming-lights system which allows you to accurately take the temperature without touching the skin, in a totally hygienic, quick and comfortable way.
Dorking Road, Tadworth
Surrey, KT20 7NS
Pfizer Inc.: Working together for a healthier world™
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world’s leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.
F. Hoffmann-La Roche Ltd
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2008, Roche had over 80,000 employees worldwide and invested almost 9 billion Swiss francs in R&D. The Group posted sales of 45.6 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.
Every day to help people stay happier and healthier longer and to reduce the human and economic burden of disease worldwide
Sanofi Pasteur MSD
8, rue Jonas Salk
69367 LYON cedex 07
Building upon the legacy of pioneers like Louis Pasteur we want to help protect people against infectious diseases so that they can live longer, feel better and achieve more. We are dedicated exclusively to vaccines because we believe prevention is better than cure and immunisation is the best prevention.
Our 45 vaccines help protect people from 20 infectious diseases, including cervical cancer, liver cancer, tuberculosis, poliomyelitis, rabies, measles, yellow fever, shingles and influenza. Our vaccines help protect everyone –from infancy to old age.
Sanofi Pasteur MSD is a joint venture between sanofi pasteur - the vaccine division of sanofi-aventis - and Merck & Co. Inc.. We develop, license, manufacture and distribute vaccines in Western Europe. We lead the vaccine industry in Western Europe with an estimated 37% of the vaccine market in 2008.
Statens Serum Institut
2300 Copenhagen S
Tel: +45 3268 8261
Fax: +45 3268 3167
Statens Serum Institut (SSI) is a public enterprise under the Ministry of Health, and has a staff of 1,400 employees.
The main products are BCG VACCINE SSI against tuberculosis, TUBERCULIN PPD RT 23 SSI for the Mantoux skin test, VeroPol against poliomyelitis and diTeBooster® for revaccination against diphtheria and tetanus.
BCG is WHO prequalified and tuberculin is recommended by WHO and IUATLD.
VeroPol is approved in several European countries.
BCG is distributed world wide through UNICEF and other business partners, and is part of the childhood immunization programme in several European countries.
SSI products are exported all over the world.
Wisepress Medical Bookshop
The Old Lamp Works
25 High Path
Wisepress.com, Europe’s leading conference bookseller, has a complete range of books and journals relevant to the themes of the meeting. Books can be purchased at the stand or, if you would rather not carry them, posted to you – Wisepress will deliver worldwide. In addition to attending 250 conferences per year, Wisepress has a comprehensive medical and scientific bookshop online with great offers, some up to 40% off the publisher list prices.